FR2073416B1 - - Google Patents

Info

Publication number
FR2073416B1
FR2073416B1 FR7042531A FR7042531A FR2073416B1 FR 2073416 B1 FR2073416 B1 FR 2073416B1 FR 7042531 A FR7042531 A FR 7042531A FR 7042531 A FR7042531 A FR 7042531A FR 2073416 B1 FR2073416 B1 FR 2073416B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7042531A
Other languages
French (fr)
Other versions
FR2073416A1 (cg-RX-API-DMAC7.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19691959403 external-priority patent/DE1959403A1/de
Priority claimed from DE19702050816 external-priority patent/DE2050816A1/de
Priority claimed from DE19702050814 external-priority patent/DE2050814A1/de
Priority claimed from DE19702050815 external-priority patent/DE2050815A1/de
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of FR2073416A1 publication Critical patent/FR2073416A1/fr
Application granted granted Critical
Publication of FR2073416B1 publication Critical patent/FR2073416B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FR7042531A 1969-11-26 1970-11-26 Expired FR2073416B1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19691959403 DE1959403A1 (de) 1969-11-26 1969-11-26 Neue 2-(5-Nitro-2-furyl)-thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung
DE19702050816 DE2050816A1 (de) 1970-10-16 1970-10-16 Neue 2-(Nitro-2-furyl>thieno eckige Klammer auf 3,2-d eckige Klammer zu pyrimidine
DE19702050814 DE2050814A1 (de) 1970-10-16 1970-10-16 Neue Verfahren zur Herstellung von 2-(5-Nitro-2-furyl)-thieno eckige Klammer auf 3,2-d eckige Klammer zu pyrimidinen
DE19702050815 DE2050815A1 (de) 1970-10-16 1970-10-16 Neue 2-(5-Nitro-2-furyl)-thieno eckige Klammer auf 3,2-d eckige Klammer zu pyrimidine

Publications (2)

Publication Number Publication Date
FR2073416A1 FR2073416A1 (cg-RX-API-DMAC7.html) 1971-10-01
FR2073416B1 true FR2073416B1 (cg-RX-API-DMAC7.html) 1975-04-18

Family

ID=27430978

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7042531A Expired FR2073416B1 (cg-RX-API-DMAC7.html) 1969-11-26 1970-11-26

Country Status (13)

Country Link
US (1) US3661908A (cg-RX-API-DMAC7.html)
BE (1) BE759493A (cg-RX-API-DMAC7.html)
BG (2) BG17799A3 (cg-RX-API-DMAC7.html)
CA (1) CA926865A (cg-RX-API-DMAC7.html)
CH (3) CH567029A5 (cg-RX-API-DMAC7.html)
DK (1) DK128781B (cg-RX-API-DMAC7.html)
FR (1) FR2073416B1 (cg-RX-API-DMAC7.html)
GB (1) GB1321316A (cg-RX-API-DMAC7.html)
IE (1) IE34765B1 (cg-RX-API-DMAC7.html)
IL (1) IL35729A (cg-RX-API-DMAC7.html)
NL (1) NL7017210A (cg-RX-API-DMAC7.html)
NO (1) NO129954B (cg-RX-API-DMAC7.html)
SE (1) SE377938B (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932642A (en) * 1971-04-10 1976-01-13 Boehringer Ingelheim Gmbh Biocidal compositions containing a 2- (5'-nitro-2'-furyl)-thieno(2,3-d) pyrimidine and methods of use
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
US6608053B2 (en) * 2000-04-27 2003-08-19 Yamanouchi Pharmaceutical Co., Ltd. Fused heteroaryl derivatives
US20040138238A1 (en) * 2002-08-08 2004-07-15 Dhanoa Dale S. Substituted aminopyrimidine compounds as neurokinin antagonists
GB0423653D0 (en) 2004-10-25 2004-11-24 Piramed Ltd Pharmaceutical compounds
EP2046799B1 (en) * 2006-04-26 2017-07-19 Genentech, Inc. Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
NZ572812A (en) * 2006-04-26 2010-09-30 Hoffmann La Roche THIENO [3, 2-D] PYRIMIDINE Indazole DERIVATIVE USEFUL AS PI3K INHIBITOR
CL2007001167A1 (es) * 2006-04-26 2008-01-25 Genentech Inc Compuestos derivados de pirimidina condensada, inhibidores de p13-quinasa; procesos para preparar los compuestos; composicion farmaceutica que los comprende; uso de los compuestos en la preparacion de medicamentos; proceso para preparar la composicion farmaceutica; y kit que incluye a la composicionfarmaceutica.
JP5284977B2 (ja) * 2006-12-07 2013-09-11 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト ホスホイノシチド3−キナーゼ阻害剤化合物及び使用方法
WO2008073785A2 (en) * 2006-12-07 2008-06-19 Genentech, Inc. Phosphoinositide 3-kinase inhibitor compounds and methods of use
EP2158207B1 (en) * 2007-06-12 2011-05-25 F. Hoffmann-La Roche AG Thiazoliopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase
EP2207781B1 (en) * 2007-09-24 2012-11-28 Genentech, Inc. Thiazolopyrimidine p13k inhibitor compounds and methods of use
WO2009055730A1 (en) * 2007-10-25 2009-04-30 Genentech, Inc. Process for making thienopyrimidine compounds
GB0721095D0 (en) * 2007-10-26 2007-12-05 Piramed Ltd Pharmaceutical compounds
MX2011009167A (es) 2009-03-12 2011-09-15 Genentech Inc Combinaciones de compuestos inhibidores de fosfoinositida 3-cinasa y agentes quimioterapeuticos para el tratamiento contra neoplasia hemotopoyeticas malignas.
EP2451811A1 (en) * 2009-05-27 2012-05-16 F. Hoffmann-La Roche AG Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
MX2011012520A (es) * 2009-05-27 2011-12-12 Hoffmann La Roche Compuestos inhibidores de pi3k de pirimidina biciclicos selectivos para p110 delta y metodos de uso de los mismos.
PE20121816A1 (es) * 2009-10-12 2013-01-02 Hoffmann La Roche Combinaciones de un inhibidor de pi3k y un inhibidor de mek
CA2793892A1 (en) 2010-04-16 2011-10-20 Elizabeth Punnoose Foxo3a as predictive biomarker for pi3k/akt kinase pathway inhibitor efficacy
US20140004209A1 (en) 2010-12-22 2014-01-02 Genentech, Inc. Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms
EP2959014B1 (en) 2013-02-25 2019-11-13 Genentech, Inc. Methods and compositions for detecting and treating drug resistant akt mutant

Also Published As

Publication number Publication date
CH568324A5 (cg-RX-API-DMAC7.html) 1975-10-31
GB1321316A (en) 1973-06-27
IE34765B1 (en) 1975-08-06
SE377938B (cg-RX-API-DMAC7.html) 1975-08-04
NO129954B (cg-RX-API-DMAC7.html) 1974-06-17
DK128781B (da) 1974-07-01
CH559210A5 (cg-RX-API-DMAC7.html) 1975-02-28
FR2073416A1 (cg-RX-API-DMAC7.html) 1971-10-01
BE759493A (fr) 1971-05-25
IL35729A0 (en) 1971-01-28
NL7017210A (cg-RX-API-DMAC7.html) 1971-05-28
IE34765L (en) 1971-05-26
IL35729A (en) 1974-01-14
BG17800A3 (bg) 1973-12-25
BG17799A3 (bg) 1973-12-25
US3661908A (en) 1972-05-09
CH567029A5 (cg-RX-API-DMAC7.html) 1975-09-30
CA926865A (en) 1973-05-22

Similar Documents

Publication Publication Date Title
AU2270770A (cg-RX-API-DMAC7.html)
AU465452B2 (cg-RX-API-DMAC7.html)
AU429630B2 (cg-RX-API-DMAC7.html)
AU450150B2 (cg-RX-API-DMAC7.html)
AU442375B2 (cg-RX-API-DMAC7.html)
AU2355770A (cg-RX-API-DMAC7.html)
AU427401B2 (cg-RX-API-DMAC7.html)
AU470301B1 (cg-RX-API-DMAC7.html)
AU442463B2 (cg-RX-API-DMAC7.html)
AU414607B2 (cg-RX-API-DMAC7.html)
AU428129B2 (cg-RX-API-DMAC7.html)
AU428131B2 (cg-RX-API-DMAC7.html)
AU425297B2 (cg-RX-API-DMAC7.html)
AU470661B1 (cg-RX-API-DMAC7.html)
AU438128B2 (cg-RX-API-DMAC7.html)
AU410358B2 (cg-RX-API-DMAC7.html)
AU442285B2 (cg-RX-API-DMAC7.html)
AU442322B2 (cg-RX-API-DMAC7.html)
AU442357B2 (cg-RX-API-DMAC7.html)
AU417208B2 (cg-RX-API-DMAC7.html)
AU442380B2 (cg-RX-API-DMAC7.html)
AT308690B (cg-RX-API-DMAC7.html)
AU442535B2 (cg-RX-API-DMAC7.html)
AU442538B2 (cg-RX-API-DMAC7.html)
AU442554B2 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
ST Notification of lapse